[Multidrug chemotherapy of osteogenic sarcoma (author's transl)]
- PMID: 291443
- DOI: 10.1007/BF01013224
[Multidrug chemotherapy of osteogenic sarcoma (author's transl)]
Abstract
Osteogenic sarcoma may be treated effectively by radical surgical removal of the primary tumor and combined chemotherapy, including Adriamycin and high dose Methotrexate. In order to render any protocol a safe procedure, strict precautions are required to avoid drug toxicity. We present a protocol, "COSS 77", presently employed in several university hospitals of West Germany and Austria. Final results concerning long term prognosis and long term side effects are not yet available.
Similar articles
-
[Therapeutic results of patients with osteogenic sarcoma by the protocol COSS 77 (author's transl)].Unfallheilkunde. 1981 Dec;84(12):524-5. Unfallheilkunde. 1981. PMID: 6948465 German. No abstract available.
-
[The use and side effects of chemotherapy in the treatment of malignant bone tumors (osteosarcoma and Ewing's sarcoma) (author's transl)].Unfallheilkunde. 1979 Dec;82(12):517-21. Unfallheilkunde. 1979. PMID: 296860 German. No abstract available.
-
Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma.Cancer. 1976 Jan;37(1):1-11. doi: 10.1002/1097-0142(197601)37:1<1::aid-cncr2820370102>3.0.co;2-3. Cancer. 1976. PMID: 1082364
-
Osteosarcoma: review of the past, impact on the future. The American experience.Cancer Treat Res. 2009;152:239-62. doi: 10.1007/978-1-4419-0284-9_12. Cancer Treat Res. 2009. PMID: 20213394 Review.
-
The therapy of osteogenic sarcoma: current status and thoughts for the future.J Surg Oncol. 1972;4(5):482-510. doi: 10.1002/jso.2930040512. J Surg Oncol. 1972. PMID: 4566220 Review. No abstract available.
Cited by
-
Osteosarcoma: improvement in survival limited to high-grade patients only.J Cancer Res Clin Oncol. 2011 Apr;137(4):597-607. doi: 10.1007/s00432-010-0923-7. Epub 2010 Jun 1. J Cancer Res Clin Oncol. 2011. PMID: 20514491 Free PMC article.